| Date | Title | | | 04/25/13 | ResMed Noninvasive Ventilation Device Cleared by FDA for COPD Treatment| First At-Home Ventilation Device Cleared Specifically for COPD Designed to Reduce Hospital Readmissions
SAN DIEGO, April 25, 2013 /PRNewswire/ -- One in five patients with stage 3 or 4 chronic obstructive pulmonary disease (COPD) hospitalized for acute exacerbations are readmitted to the hospital within 30 days, but these readmissions may be avoided with the right at-home therapy, according to ResMed (NYSE: RMD), an innovator and pioneer in developing products for the treatment of sleep-disor... |
|  | | 04/25/13 | ResMed Inc. Announces Record Financial Results For The Quarter Ended And Nine Months Ended March 31, 2013| SAN DIEGO, April 25, 2013 /PRNewswire/ -- ResMed Inc. (NYSE: RMD) today announced record revenue and income for the quarter ended March 31, 2013. Revenue for the quarter ended March 31, 2013 was $383.6 million, a 10% increase (also a 10% increase on a constant currency basis) over the quarter ended March 31, 2012. For the quarter ended March 31, 2013, net income was $84.9 million, an increase of 31% compared to the quarter ended March 31, 2012. Diluted earnings per share for the quarter ended... |
| | | 04/03/13 | ResMed Announces Conference Call And Webcast To Discuss Third Quarter 2013 Results| SAN DIEGO, April 3, 2013 /PRNewswire/ -- RESMED INC. (NYSE: RMD) announced today that on Thursday, April 25, 2013, it will release its results for the third quarter and nine months of fiscal year 2013, ended March 31, 2013. A press release with ResMed's results will be issued after 1:00 p.m. US Pacific Time and the company will host a conference call and webcast to review its results, market trends, and future outlook.
(Logo: http://photos.prnewswire.com/prnh/20100203/RESMEDLOGO)
The confe... |
| | | 03/28/13 | ResMed Takes Action to Enforce Patents| Suit Filed against APEX Medical Corp. for Patent Infringement on Devices and Masks
SAN DIEGO, March 28, 2013 /PRNewswire/ -- ResMed, an innovator and pioneer in developing products for the treatment of sleep-disordered breathing and respiratory conditions, has filed parallel legal actions in the International Trade Commission (ITC) and in U.S. federal court to stop the infringement of ResMed patents.
(Logo: http://photos.prnewswire.com/prnh/20100203/RESMEDLOGO)
ResMed filed the actio... |
| |
|
Print Page | 
E-mail Page | 
RSS Feeds | 
E-mail Alerts | 
IR/PR Contacts | 
Financial Tear Sheet